Seattle Mariners infielder Colt Emerson's rookie season has ended prematurely.

Ryan Divish of The Seattle Times reported that Emerson will have surgery on his left wrist. Although Emerson will miss the rest of the season, Divish further reported that the infielder is expected to be ready for spring training.

A highly regarded prospect, Emerson had signed an eight-year, $95 million extension shortly after Opening Day. He made his major league debut on May 17 and was expected to help jumpstart the Mariners offense. However, he produced a disappointing .190/.246/.335 batting line with eight homers and six doubles in his 241 plate appearances. Emerson had been slated to return to Triple-A when he landed on the Injured List due to left wrist tendon inflammation.

A healthy Colt Emerson could make an impact on Seattle Mariners in 2027

Emerson's wrist issues could explain his lack of production. Adam Jude of The Seattle Times reported on Aug. 14 that Emerson's wrist had been bothering him since April. He had received a cortisone injection and missed five games before returning to the lineup.

Emerson had been regarded as a solid all-around prospect with a potential plus hit tool and above-average power. He showed flashes of that potential, but his 85 strikeouts, subpar hard-hit rate (31.2% vs. 38.9% league average), and exit velocity (85.7 MPH vs. 88.1 MPH league average) limited his impact. 

It is possible that Emerson's ongoing wrist issues caused his unexpectedly poor performance in Seattle. Should that be the case, Emerson could take his place as a key part of the Mariners lineup once he is healthy again.